Navigation Links
SeqWright Continues Expansion of Next-Generation Sequencing Capabilities
Date:1/11/2011

HOUSTON, Jan. 11, 2011 /PRNewswire/ -- SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, continues to make significant strides to position itself as the Next-Generation Sequencing Provider of choice for 2011. SeqWright's ongoing success can be attributed to the company's ability to respond quickly to customer's demands and by investing in key genomics technologies. Building on this success, SeqWright announced today the expansion of its Next-Generation Sequencing capacity by the acquisition of a second Illumina HiSeq 2000.

SeqWright has also expanded its bioinformatics capabilities with the acquisition of the PowerWulf GRaNDE Compute Engine from PSSC Labs, significantly increasing workflow. SeqWright's bioinformatics experts can map Next-Generation sequencing runs in under 24 hours, map multiple jobs at once, and map from multiple platforms simultaneously. This allows SeqWright to process more large-scale Next-Generation sequencing projects in less time, improving operational efficiency and increasing throughput. SeqWright's Next-Generation data management system, Isilon IQ, has also been augmented with increased storage and archiving tape capacity and a dedicated archiving server. These changes enhance SeqWright's regulatory compliance by meeting the back-up requirements of customers and regulatory agencies, consistent with SeqWright's focus on expanding its GLP and CLIA offerings.

With the Roche 454 GS FLX Titanium, AB SOLiD 4 and Illumina HiSeq 2000 Next-Generation Sequencing Platforms, an array of sequence capture and target enrichment technologies, and advanced data analysis and storage, SeqWright is positioned to offer the best solutions under one roof. SeqWright's Next-Generation services continue to expand and includes de Novo sequencing, SNP analysis (regulatory validated for the Roche 454 GS FLX Titanium), RNA and cancer genome sequencing. SeqWright continues to focus on offering project-specific solutions to its wide range of clients, from pharmaceutical companies to academia, while continuing to evaluate the market for the next advancement in the life science industry.

About SeqWright

Based in Houston, TX, SeqWright Incorporated is recognized as an international leader in the field of contract genomic services, including Next-Generation sequencing. For over sixteen years, SeqWright has provided state-of-the-art Molecular Biology and Genomic services, from small projects up to full clinical trials. SeqWright has received a license from the state of California to operate as a clinical laboratory. This license, along with its CLIA certification, allows SeqWright to handle clinical samples from the vast majority of the United States. For additional information about SeqWright and its services, please visit www.seqwright.com.


'/>"/>
SOURCE SeqWright Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SeqWright Announces the Addition of Illumina HiSeq 2000 to its Next Generation Sequencing Capabilities
2. SeqWright Expands Genomics Services Offering Through New Partnership With RainDance Technologies
3. SeqWright Expands into the Genetically-Targeted Therapy Field by Partnering with PharmaGenoma to Provide Next-Generation Hair Loss Treatment Genetic Testing
4. SeqWright to Invest in LaserGens Novel Lightning Terminators(TM)
5. California Grants SeqWright License to Operate as a Clinical Laboratory
6. Fourth Annual Probiotics Grant Continues to Fuel Growth In Research
7. IGEN Networks Corp continues to build a world class advisory board, with the appointment of three new members
8. Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation
9. New Test Centre in India: TUV Rheinland Continues Worldwide Investment Programme for Solar Industry
10. Simbionix Continues its Global Expansion
11. O2h Continues to Support Senexis to Support Patent Filing Senexis Limited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission ... hardware projects are designed, built and brought to market. , The Design Lab ...
(Date:6/23/2016)...  Blueprint Bio, a company dedicated to identifying, protecting ... has closed its Series A funding round, according to ... "We have received a commitment from Forentis Fund that ... meet our current goals," stated Matthew Nunez . ... complete validation on the current projects in our pipeline, ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):